Sarcopenia, obesity, and inflammation—results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study
Matteo Cesari(University of Vermont), Stephen B. Kritchevsky(University of Vermont), Richard Baumgartner(University of Vermont), Hal H. Atkinson(University of Vermont), B. Penninx(University of Vermont), Leon Lenchik(University of Vermont), Shana L. Palla(University of Vermont), Walter T. Ambrosius(University of Vermont), Russell P. Tracy(University of Vermont), Marco Pahor(University of Vermont)
Cited by 371Open Access
Abstract
Related Papers
Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index
Dympna Gallagher, Steven B. Heymsfield, Moonseong Heo et al.|American Journal of Clinical Nutrition|2000|2.1k
Sarcopenia: Alternative Definitions and Associations with Lower Extremity Function
Anne B. Newman, Varant Kupelian, Marjolein Visser et al.|Journal of the American Geriatrics Society|2003|973